Updates are available Correction dated 2019-07-17
Click to view Correction: https://doi.org/10.1038/s41591-019-0546-8
-
Authors
Kirjavainen, Pirkka V. http://orcid.org/0000-0001-6119-8768
Karvonen, Anne M. http://orcid.org/0000-0003-2257-2934
Adams, Rachel I.
Täubel, Martin http://orcid.org/0000-0001-8082-1041
Roponen, Marjut
Tuoresmäki, Pauli
Loss, Georg
Jayaprakash, Balamuralikrishna
Depner, Martin
Ege, Markus Johannes http://orcid.org/0000-0001-6643-3923
Renz, Harald
Pfefferle, Petra Ina
Schaub, Bianca
Lauener, Roger http://orcid.org/0000-0002-8412-606X
Hyvärinen, Anne
Knight, Rob http://orcid.org/0000-0002-0975-9019
Heederik, Dick J. J.
von Mutius, Erika
Pekkanen, Juha
- License Information
-
More Information
Article History
Received: 23 April 2018
Accepted: 25 April 2019
First Online: 17 June 2019
Change Date: 17 July 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: P.V.K., A.M.K., R.I.A., M.T., M.R., P.T., G.L., B.J., M.D., H.R., P.I.P., B.S., R.L., A.H., D.J.J.H. and J.P. do not have competing interests to disclose. M.J.E. and E.v.M. report patents EP2361632B1 and EP1964570B1 held by their institution LMU. E.v.M. reports being the recipient of funds from the European Commission for the conduct of the LUKAS (EFRAIM) and GABRIEL study and declares personal fees from Pharma Ventures, Peptinnovate Ltd, OM Pharma SA, the European Commission/European Research Council Executive Agency, Tampereen Yliopisto, the University of Turku, HAL Allergie GmbH, Ökosoziales Forum Oberösterreich and Mundipharma Deutschland GmbH & Co. KG; E.v.M. is an inventor on the patents EP1637147, EP1964570, LU101064 and EP1411977; E.v.M. is an inventor on and has received royalties from the patent EP2361632. R.K. is on the Scientific Advisory Board of Commense, Inc.
